IMPAIRED CELL-MEDIATED-IMMUNITY IN EXPERIMENTAL ABDOMINAL SEPSIS AND THE EFFECT OF INTERLEUKIN-2

被引:0
|
作者
GOUGH, DB [1 ]
JORDAN, A [1 ]
MANNICK, JA [1 ]
RODRICK, ML [1 ]
机构
[1] HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT SURG, 75 FRANCIS ST, BOSTON, MA 02115 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A murine model of experimental sepsis, ie, cecal ligation and puncture, was used to determine the potential effects of infection on in vitro cell-mediated immunity. Following cecal ligation and puncture, in vitro responses of mouse splenocytes to mitogens (phytohemagglutinin and concanavalin A), the effects of in vitro interleukin 2 on these responses, and the impact of in vivo interleukin 2 on survival were studied. Compared with controls (sham cecal ligation and puncture), phytohemagglutinin responses 1 day after cecal ligation and puncture were enhanced (43%+/-17%, n = 9), phytohemagglutinin and concanavalin A responses at day 4 were suppressed (45.5%+/-4.4% and 57.5%+/-5.6%), and, by day 7, phytohemagglutinin and concanavalin A responses were approaching values in mice treated by sham cecal ligation and puncture. Suppressed phytohemagglutinin responses at day 4 after cecal ligation and puncture were restored to normal with in vitro interleukin 2 (61 052+/-3407 cpm for cecal ligation and puncture and 64 643+/-4727 cpm for sham cecal ligation and puncture). Mortalities following cecal ligation and puncture were identical at day 1 after cecal ligation and puncture (6/20) for both interleukin 2- and vehicle-treated groups; thereafter, interleukin 2-treated groups fared better. At day 1 after cecal ligation and puncture, the mean spleen cell phytohemagglutinin response was enhanced (43.8%+/-17%, n = 9) compared with sham cecal ligation and puncture (= 10). By day 4, the responses to both concanavalin A and phytohemagglutinin were suppressed (45.5%+/-4.4% and 57.5%+/-5.6%, respectively). Responses at day 7 approached those of controls given sham cecal ligation and puncture. Sepsis causing a temporary impairment of cell-mediated immunity may be a factor in the frequent coexistence of altered cell-mediated immunity and sepsis, and interleukin 2 may have a role in limiting the adverse effects of sepsis.
引用
收藏
页码:859 / 863
页数:5
相关论文
共 50 条
  • [1] EFFECT OF IBUPROFEN AND INTERLEUKIN-2 ON TRANSFUSION-INDUCED SUPPRESSION OF CELL-MEDIATED-IMMUNITY
    SHELBY, J
    HISATAKE, G
    ARCHIVES OF SURGERY, 1988, 123 (11) : 1397 - 1399
  • [2] THE RECONSTITUTION OF CELL-MEDIATED-IMMUNITY IN THE CUTANEOUS LESIONS OF LEPROMATOUS LEPROSY BY RECOMBINANT INTERLEUKIN-2
    KAPLAN, G
    KIESSLING, R
    TEKLEMARIAM, S
    HANCOCK, G
    SHEFTEL, G
    JOB, CK
    CONVERSE, P
    OTTENHOFF, THM
    BECXBLEUMINK, M
    DIETZ, M
    COHN, ZA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03): : 893 - 907
  • [3] MECHANISMS OF SUPPRESSED CELL-MEDIATED-IMMUNITY AND IMPAIRED ANTIGEN-INDUCED INTERLEUKIN-2 PRODUCTION IN GRANULOMA-BEARING MICE
    KOBAYASHI, K
    ALLRED, C
    YOSHIDA, T
    JOURNAL OF IMMUNOLOGY, 1985, 135 (05): : 2996 - 3003
  • [4] INHIBITION OF CELL-MEDIATED-IMMUNITY BY TUMOR-CELL PRODUCTS - DEPRESSION OF INTERLEUKIN-2 PRODUCTION AND RESPONSES TO INTERLEUKIN-2 BY MOUSE SPLEEN-CELLS
    NELSON, M
    NELSON, DS
    IMMUNOLOGY AND CELL BIOLOGY, 1988, 66 : 97 - 104
  • [5] DEFECTIVE CELL-MEDIATED IMMUNITY IN SARCOIDOSIS - EFFECT OF INTERLEUKIN-2
    LYONS, DJ
    GAO, L
    MITCHELL, EB
    MITCHELL, DN
    THORAX, 1988, 43 (12) : 992 - 997
  • [6] IMPAIRED CELL-MEDIATED-IMMUNITY IN LIPOID NEPHROSIS
    MATSUMOTO, K
    OSAKABE, K
    HARADA, M
    HATANO, M
    NEPHRON, 1981, 29 (3-4) : 190 - 194
  • [7] CELL-MEDIATED-IMMUNITY IN EXPERIMENTAL TOXOPLASMOSIS
    GUPTA, SL
    GAUTAM, OP
    BHARDWAJ, RM
    BANERJEE, DP
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1980, 71 (APR) : 526 - 530
  • [8] IMPAIRED CELL-MEDIATED-IMMUNITY IN PATIENTS WITH CLASSIC HEMOPHILIA
    LEDERMAN, MM
    RATNOFF, OD
    SCILLIAN, JJ
    JONES, PK
    SCHACTER, B
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (02): : 79 - 83
  • [9] IMPAIRED CELL-MEDIATED-IMMUNITY IN SICKLE-CELL-ANEMIA
    KAUR, P
    COOPER, R
    ALEXANDER, J
    WALTERS, TR
    OLESKE, J
    CLINICAL RESEARCH, 1982, 30 (02): : A513 - A513
  • [10] IMPAIRED CELL-MEDIATED-IMMUNITY IN FOCAL GLOMERULAR SCLEROSIS
    MATSUMOTO, K
    OSAKABE, K
    KATAYAMA, H
    YOSHIZAWA, N
    NAGURA, Y
    HARADA, M
    FUJITA, T
    OHI, H
    HATANO, M
    NEPHRON, 1983, 34 (04): : 220 - 223